International Aloe Science Council Sign Up Information

Alain Touwaide, Ph.D., will deliver the keynote presentation at AHPA's Annual Member Meeting on March 4 at Expo West in Anaheim, CA. Dr. Touwaide researches the history of ancient science, particularly botany, medicinal plants, medicine and therapeutics in the Mediterranean World from archaic Greece to the Ottoman Empire. He has been in residence in medical schools, colleges of pharmacy, and faculties of sciences across the globe in a scientific Grand Tour that included the Botany Department of the Smithsonian Institution over the past 15 years. At the same time, he has been searching for Greek manuscripts and texts on these topics in libraries all over the world, and has been doing research and teaching in departments of Classics and History, centers for Byzantine studies, and faculties of Humanities worldwide. To better foster the development of original research in this vast and complex field of research he co-founded the Institute for the Preservation of Medical Traditions in 2007. The most recent of his multiple publications is A Census of Greek Medical Manuscripts (London and New York: Routledge, 2016) published in the series Medicine in the Medieval Mediterranean that he has created.

AHPA's Annual Member Meeting features insights into industry trends, the board of trustees' election, and the presentation of the 2020 AHPA Awards. Register today to reserve your seat.

Additional information about AHPA's Expo West meetings and events schedule is available at AHPA.org.

AHPA's member meeting is open to non-members. Non-members wishing to attend should contact Amber Bennett at membership@ahpa.org or 301.588.1171 x105.

Alain Touwaide, Ph.D., will deliver the keynote presentation at AHPA's Annual Member Meeting on March 4 at Expo West in Anaheim, CA. Dr. Touwaide researches the history of ancient science, particularly botany, medicinal plants, medicine and therapeutics in the Mediterranean World from archaic Greece to the Ottoman Empire. He has been in residence in medical schools, colleges of pharmacy, and faculties of sciences across the globe in a scientific Grand Tour that included the Botany Department of the Smithsonian Institution over the past 15 years. At the same time, he has been searching for Greek manuscripts and texts on these topics in libraries all over the world, and has been doing research and teaching in departments of Classics and History, centers for Byzantine studies, and faculties of Humanities worldwide. To better foster the development of original research in this vast and complex field of research he co-founded the Institute for the Preservation of Medical Traditions in 2007. The most recent of his multiple publications is A Census of Greek Medical Manuscripts (London and New York: Routledge, 2016) published in the series Medicine in the Medieval Mediterranean that he has created.

AHPA's Annual Member Meeting features insights into industry trends, the board of trustees' election, and the presentation of the 2020 AHPA Awards. Register today to reserve your seat.

Additional information about AHPA's Expo West meetings and events schedule is available at AHPA.org.

AHPA's member meeting is open to non-members. Non-members wishing to attend should contact Amber Bennett at membership@ahpa.org or 301.588.1171 x105.

Half-day workshops being presented at AHPA's Hemp-CBD Supplement Congress will cover current good manufacturing practice (cGMP) for hemp-CBD, New Dietary Ingredient (NDI) and Generally Recognized as Safe (GRAS), laboratory and testing issues, and good agricultural collection practices (GACP). Register today to reserve your seat

This AHPA webinar will review this recent CA Prop 65 developments and how other provisions of Prop 65 apply to the legal cannabis industry, including marketers of hemp-derived CBD products who are in commerce in the state of California.

Prop 65, officially known as the Safe Drinking Water and Toxic Enforcement Act of 1986, requires businesses to inform Californians about exposures to chemicals known to cause cancer, birth defects or other reproductive harm, and requires the State to maintain and update a list of these chemicals on a yearly basis. The Office of Environmental Health Hazard Assessment (OEHHA) is the lead agency for the assessment of health risks posed by environmental contaminants, and is the agency tasked with implementing Prop 65.

Pursuant to Prop 65, companies conducting business in California must provide a clear and reasonable warning to consumers about exposures to any of the 940+ chemicals on OEHHA’s list, unless the exposures do not exceed established threshold levels. The warning message must be available to the consumer prior to exposure. This webinar will provide an overview of the clear and reasonable warning regulation, including recent changes and amendments.

Prop 65 disputes are primarily enforced via private litigation, which is why compliance is absolutely key to your business. This webinar will provide an overview of several significant developments related to Prop 65. Companies that sell products in California should understand these recent changes and be prepared for additional changes that are in development. A solid compliance plan will help your company mitigate the risk of expensive litigation.

In comments submitted to U.S. Department of Agriculture (USDA), Agricultural Marketing Service (AMS), AHPA requested numerous, significant revisions to the Interim Final Rule (IFR) that establishes a domestic hemp production program before a Final Rule is promulgated in 2021.

AMS has indicated the IFR will be in effect for two years, impacting hemp production during the 2020 and 2021 hemp growing seasons. However, a number of states have already announced they will continue to operate their hemp production programs under the provisions of the 2014 Farm Bill for the 2020 growing season due to the timing of the release of the IFR in late 2019 and technical details that represent significant implementation challenges are the reason for this decision. Some states have also cited the lack of qualified analytical laboratories that meet the requirements defined in the IFR as another consideration.

AHPA also strongly recommended that AMS conduct another public comment period towards the conclusion of the 2020 hemp growing season to allow for first-hand experience with the IFR provisions to inform the Final Rule.

AHPA also highlighted ways to improve the separate sampling and testing guidelines issued by AMS:

On October 31, 2019, the USDA AMS issued the IFR titled “Establishment of a Domestic Hemp Production Program.” As mandated by the Agricultural Improvement Act of 2018 (2018 Farm Bill), the IFR outlines provisions for AMS “to approve plans submitted by States and Indian Tribes for the domestic production of hemp.” The IFR also “establishes a Federal plan for producers in States or territories of Indian Tribes that do not have their own USDA approved plan.”

This event will be the highlight of your Expo West visit. Sign up for the HerbWalk using the "Add À La Carte Options" link when you register for Expo West.

Erin Smith, MSc, CCH, is a clinical herbalist and ethnobotanist and has been working with medicinal plants for over 25 years. Bringing together her passion for plants and cultures, Smith received her masters of science in ethnobotany with distinction from the University of Kent in Canterbury, where her thesis focused on women’s knowledge of traditional medicine in Morocco. For 10 years, she worked internationally with indigenous communities on various issues surrounding traditional medicine, natural resource management, community-based conservation, and traditional knowledge. Smith has taught internationally on herbal medicine, ethnobotany, and the human/nature relationship for 15 years and has spent more than 12 years living and working abroad in more than 20 countries. She currently oversees education and sustainability at WishGarden Herbs in Colorado as their education and sustainability manager and consults and teaches internationally on herbal medicine and ethnobotany. Smith is the creator of Plant-Passionate Living™, an interactive program for greater health and vitality through a deeper relationship with plants.

Due to overwhelming demand, AHPA is presenting a second, expanded Hemp-CBD Supplement Congress in Portland, OR to provide companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market.

This AHPA webinar will review this recent CA Prop 65 developments and how other provisions of Prop 65 apply to the legal cannabis industry, including marketers of hemp-derived CBD products who are in commerce in the state of California.

Prop 65, officially known as the Safe Drinking Water and Toxic Enforcement Act of 1986, requires businesses to inform Californians about exposures to chemicals known to cause cancer, birth defects or other reproductive harm, and requires the State to maintain and update a list of these chemicals on a yearly basis. The Office of Environmental Health Hazard Assessment (OEHHA) is the lead agency for the assessment of health risks posed by environmental contaminants, and is the agency tasked with implementing Prop 65.

Pursuant to Prop 65, companies conducting business in California must provide a clear and reasonable warning to consumers about exposures to any of the 940+ chemicals on OEHHA’s list, unless the exposures do not exceed established threshold levels. The warning message must be available to the consumer prior to exposure. This webinar will provide an overview of the clear and reasonable warning regulation, including recent changes and amendments.

Prop 65 disputes are primarily enforced via private litigation, which is why compliance is absolutely key to your business. This webinar will provide an overview of several significant developments related to Prop 65. Companies that sell products in California should understand these recent changes and be prepared for additional changes that are in development. A solid compliance plan will help your company mitigate the risk of expensive litigation.

The finalized schedule of AHPA events at Expo West in Anaheim, CA from March 3 to 8 is now available online.

Events include the Annual Member Meeting, Member Reception, HerbWalk and committee meetings.

FINAL schedule with event rooms (Download)

Half-day workshops being presented at AHPA's Hemp-CBD Supplement Congress will cover current good manufacturing practice (cGMP) for hemp-CBD, New Dietary Ingredient (NDI) and Generally Recognized as Safe (GRAS), laboratory and testing issues, and good agricultural collection practices (GACP). Register today to reserve your seat

Due to overwhelming demand, AHPA is presenting a second, expanded Hemp-CBD Supplement Congress in Portland, OR to provide companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market.

The finalized schedule of AHPA events at Expo West in Anaheim, CA from March 3 to 8 is now available online.

Events include the Annual Member Meeting, Member Reception, HerbWalk and committee meetings.

FINAL schedule with event rooms (Download)

The FTC enforces against false, misleading, and deceptive advertising in any medium. For example, under these authorities, the agency requires that advertisers have adequate substantiation for their claims and provide appropriate disclosures. As technology has changed how and where firms advertise products, the FTC has developed principles for applying its authorities to new media and marketing practices. Learn how testimonials and social media can trip you up if you are not paying attention to these principles, which govern not only FTC enforcement but also the approaches taken by state law enforcement agencies (e.g., attorneys general offices), Plaintiffs’ lawyers who seek to put your money in their pockets, self-regulatory bodies, and competitors challenging your marketing.

Click here (nweaver@ahpa.org) to submit questions BEFORE the webinar so presenters can address YOUR ISSUES during their presentation. A 20-30-minute Q&A session will follow the speaker presentations to answer specific questions submitted in advance.

The FTC enforces against false, misleading, and deceptive advertising in any medium. For example, under these authorities, the agency requires that advertisers have adequate substantiation for their claims and provide appropriate disclosures. As technology has changed how and where firms advertise products, the FTC has developed principles for applying its authorities to new media and marketing practices. Learn how testimonials and social media can trip you up if you are not paying attention to these principles, which govern not only FTC enforcement but also the approaches taken by state law enforcement agencies (e.g., attorneys general offices), Plaintiffs’ lawyers who seek to put your money in their pockets, self-regulatory bodies, and competitors challenging your marketing.

Click here (nweaver@ahpa.org) to submit questions BEFORE the webinar so presenters can address YOUR ISSUES during their presentation. A 20-30-minute Q&A session will follow the speaker presentations to answer specific questions submitted in advance.